Online Journal Club: Clinical Data Review of RHA 2,3,4 HA Filler

The TITAN Online Journal Club welcomes Conor Gallagher, Vice President of Medical Affairs for Revance Therapeutics, to discuss the published data for RHA 2,3 and 4 hyaluronic acid fillers.  The papers to be discussed are “Efficacy and safety of a new resilient hyaluronic acid dermal
filler, in the correction of moderate‐to‐severe nasolabial folds:
A 64‐week, prospective, multicenter, controlled, randomized,
double‐blind and within‐subject study” and “Efficacy and Safety of Two Resilient Hyaluronic Acid
Fillers in the Treatment of Moderate-to-Severe
Nasolabial Folds: A 64-Week, Prospective, Multicenter,
Controlled, Randomized, Double-Blinded, and Within- Subject Study”.